Cocrystal Pharma (STU:8CC) Current Accrued Expense : €0.71 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Cocrystal Pharma Current Accrued Expense?

Cocrystal Pharma's Current Accrued Expense for the quarter that ended in Mar. 2024 was €0.71 Mil.

Cocrystal Pharma's quarterly Current Accrued Expense increased from Sep. 2023 (€1.00 Mil) to Dec. 2023 (€1.55 Mil) but then declined from Dec. 2023 (€1.55 Mil) to Mar. 2024 (€0.71 Mil).

Cocrystal Pharma's annual Current Accrued Expense declined from Dec. 2021 (€0.54 Mil) to Dec. 2022 (€0.22 Mil) but then increased from Dec. 2022 (€0.22 Mil) to Dec. 2023 (€1.55 Mil).

Cocrystal Pharma Current Accrued Expense Historical Data

The historical data trend for Cocrystal Pharma's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cocrystal Pharma Current Accrued Expense Chart

Cocrystal Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

0.36

0.24

0.54

0.22

1.55

Cocrystal Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															0.14	0.21	1.00	1.55	0.71

Cocrystal Pharma Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Cocrystal Pharma Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cocrystal Pharma's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cocrystal Pharma (STU:8CC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cocrystal Pharma Inc (STU:8CC) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

COCP:USA

Address

19805 North Creek Parkway, Bothell, WA, USA, 98011

Website

https://www.cocrystalpharma.com

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Cocrystal Pharma (STU:8CC) Headlines

No Headlines